Information Provided By:
Fly News Breaks for December 16, 2019
WPX, CAH, URBN, PEP, AMRN
Dec 16, 2019 | 10:12 EDT
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. PepsiCo (PEP) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Dara Mohsenian citing valuation. 2. Urban Outfitters (URBN) downgraded to Hold from Buy at Loop Capital with analyst Laura Champine saying although the stock price has bounced following an earnings miss driven sell-off last month, she warns that the company's promotional activity has intensified recently among specialty apparel retailers and believes that FY20 EPS consensus has not come down low enough. 3. Amarin (AMRN) downgraded to Hold from Buy at Stifel with analyst Derek Archila saying "there is no doubt in our mind Vascepa will be a multi-billion dollar product," he prefers to "take profits" at the stock's current valuation near $11B fully diluted. 4. Cardinal Health (CAH) downgraded to Neutral from Buy at Guggenheim with analyst Glen Santangelo saying he sees a more balanced risk/reward at current share levels. 5. WPX Energy (WPX) downgraded to Hold from Buy at SunTrust with analyst Neal Dingmann citing the Bloomberg report late on Friday that the company was in talks to buy Felix Energy's upstream assets for $2.5B. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
News For PEP;URBN;AMRN;CAH;WPX From the Last 2 Days
AMRN
Feb 18, 2020 | 11:20 EDT
Shares of Amarin (AMRN) are on the rise on Tuesday after Citi analyst Joel Beatty upgraded the stock to Buy from Neutral, arguing that now is an attractive time to buy with the shares trading 27% lower since November. Further, the analyst... To see the rest of the story go to thefly.com. See Story Here
AMRN
Feb 18, 2020 | 10:33 EDT
Check out today's top analyst calls from around Wall Street, compiled by The Fly. TESLA TARGETS RAISED... To see the rest of the story go to thefly.com. See Story Here
AMRN
Feb 18, 2020 | 10:15 EST
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Amarin (AMRN) upgraded to Buy from Neutral at Citi with analyst Joel Beatty saying with the stock trading 27% lower since November, now is an attractive time to buy. 2. Duke Energy (DUK) upgraded to Outperform from Neutral at Credit Suisse with analyst Michael Weinstein sayin he sees last year's $2.5B equity forward that was issued to support any contingency associated with the Atlantic Coast Pipeline project as providing Duke Energy the flexibility to fund additional accretive organic growth in the meantime. 3. Knowles (KN) upgraded to Overweight from Neutral at Piper Sandler with analyst Harsh Kumar saying he expects the operational issues affecting March quarter gross margin and the demand concerns surrounding Chinese handsets to ease entering the June 2020 quarter. 4. Brunswick (BC) upgraded to Outperform from Market Perform at Raymond James with analyst Joseph Altobello saying Brunswick has emerged as the pure-play leader in the U.S. marine industry with a balanced portfolio across boats, engines and parts and accessories. 5. WWE (WWE) upgraded to Overweight from Equal Weight at Consumer Edge. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
AMRN
Feb 18, 2020 | 06:05 EST
Citi analyst Joel Beatty upgraded Amarin to Buy from Neutral with a price target of $24, down from $27. The shares closed Friday down 7c to $17.62. With the stock trading 27% lower since November, now is an attractive time to buy, Beatty tells investors in a research note. The analyst still believes Vascepa sales will "accelerate strongly" over the next couple years. Further, Amarin will likely emerge from the ongoing intellectual property litigation with Vascepa exclusivity largely intact, contends Beatty.
AMRN
Feb 18, 2020 | 06:01 EST
Citi analyst Joel Beatty upgraded Amarin to Buy from Neutral with a price target of $24, down from $27.